Other studies attempted to combine the vaccine injection with adjusting the immunosuppressive milieu of the tumor microenvironment to a more immunogenic one — for example, by blocking inhibitory receptors such as PD-1/PD-L1 (62). This evidence concerns the gene CD274 and neoplasm.